MMSI
Strong BuyPremium GrowerFLAGMerit Medical Systems, Inc. · Healthcare · United States · $5.4B · Avg Vol: $61M/d
Premium Grower: Strong business with the market behind it, but you are paying up for it.
Insufficient evidence for a screen-pass. Merit Medical Systems, Inc.: fails the quant gate on value (Q65/V41/M71; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
ABOUT MERIT MEDICAL SYSTEMS, INC.
Read
Merit Medical Systems develops, manufactures, and distributes disposable medical devices for interventional cardiology, radiology, oncology, and endoscopy. The company maintains a strong global presence and diverse product portfolio in specialized medical device markets. It serves as a key supplier for hospitals and clinics worldwide, focusing on niche interventional and diagnostic device categories.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.3B | 1.4B | 1.5B | 9.6% | 1.6B | 1.6B | 1.7B | 7.0% |
| EPS | 1.31 | 1.64 | 2.07 | 2.17 | 18.3% | 2.43 | 2.44 | 2.61 | 9.7% |
| Shares | 57.3M | 57.9M | 58.7M | 59.4M | +3.7% | 59.7M | — | — | — |
| Debt | 268.8M | 891.4M | 794.7M | 821.6M | 45.1% | 820.1M | — | — | — |
| Equity | 1.1B | 1.2B | 1.4B | 1.6B | 11.5% | — | — | — | — |
| Op CF | 114.3M | 145.2M | 220.8M | 297.4M | 37.5% | 283.4M | — | — | — |
| Inv CF | -57.4M | -175.3M | -368.7M | -247.4M | — | — | — | — | — |
| Fin CF | -60.3M | 559.3M | -60.0M | 16.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MMSI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MMSI | Merit Medical Systems, Inc.(you) | $5.4B | 82 | Strong Buy |
| NVST | Envista Holdings Corporation | $4.4B | 85 | Strong Buy |
| ATR | AptarGroup, Inc. | $8.5B | 74 | Buy |
| TFX | Teleflex Incorporated | $5.9B | 66 | Buy |
| ALGN | Align Technology, Inc. | $11.2B | 85 | Strong Buy |
| SOLV | Solventum Corporation | $15.5B | 83 | Strong Buy |
| ICUI | ICU Medical, Inc. | $4.4B | 63 | Hold |
| AVTR | Avantor, Inc. | $9.9B | 70 | Buy |
| BAX | Baxter International Inc. | $13.5B | 73 | Buy |
| ATRC | AtriCure, Inc. | $2.5B | 64 | Hold |
Peer medians: ROE -31.0% · P/E 25.0x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.